APAP) analgesic (OC/APAP ER), is a bilayer product with immediate-release (IR) and extended-release (ER) properties. Two single-center, open-label, randomized, phase 1, crossover studies were conducted
multicenter, open-label, single-arm, crossover study evaluated the safety and efficacy of paliperidone extended-release (ER) in patients with schizophrenia or schizoaffective disorder and hepatic disease. Methods: The…
Oral extended-release delivery of Biopharmaceutics Classification System (BCS) class II and III compounds is desirable in order to decrease dosing frequency and potential adverse effects. Maintaining an extended-release…
sourced physiological model for immediate-release (IR) methylphenidate (MPH), with addition of parameters for extended-release (ER) absorption can be adapted for NONMEM analysis to describe extended-release MPH drug
Aptensio XR® is an Extended-Release (ER) Methylphenidate (MPH) capsule drug product, approved for use in patients 6 years and above. Clinical studies have been conducted in adults
open-label, flexibledose clinica l trial. All participants received a flexible dose of paliperidone extended-release(ER) of between 3 and 12 mg. Treatment efficacy was measured using Personal
this study was to design, optimize, and evaluate Nevirapine extended-release tablets (100 mg/400 mg) to enhance the therapeutic efficacy and patient compliance in the treatment of HIV/AIDS.The ... extended period, while…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.